LINDSAY LEPAGE: Open Payments
NPI 1548305014 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 43 payments from 18 companies in 2025. Trend: 2023 $896 · 2024 $1,196 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $166 |
| Novo Nordisk Inc | 6 | $115 |
| Eisai Inc. | 3 | $81 |
| Amgen Inc. | 4 | $70 |
| PFIZER INC. | 4 | $67 |
| SANOFI-AVENTIS U.S. LLC | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Abbott Laboratories | 2 | $43 |
| ABBVIE INC. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
Products named: Veozah, Leqembi, TZIELD, Rybelsus, Ozempic, EVENITY, LEQVIO, FREESTYLE LIBRE 3.
Industry payments across GA — which companies pay providers there.
